Nonspecific Regulation of the Number of Immunocompetent Cells Under the Influence of DT Toxoid in Children With Glomerulonephritis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 26 05 2021
accepted: 17 09 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 21 12 2021
Statut: epublish

Résumé

Studies aimed at identifying the mechanisms of the immunoregulatory effect of vaccination with diphtheria and tetanus toxoid on the parameters of adaptive immunity in children with kidney pathology are limited. The study aimed to study the effect of revaccination against diphtheria and tetanus on the proliferation and differentiation of immunocompetent cells, the formation of specific antibodies, and the course of the disease in children with glomerulonephritis (GN). The study included 45 children with glomerulonephritis (GN) aged 5 to 15 years, in remission from 6 months up to 4 years. Of these, 25 children were revaccinated with DT toxoid (Diphtheria-Tetanus toxoid with reduced antigenic content) and 20 were in the control group (not vaccinated). The frequency of development of local and systemic reactions and the course of GN were assessed. The subpopulation structure of lymphocytes was studied in dynamics after 1-6-12 months by flow cytometry and IgG levels to diphtheria and tetanus were studied by ELISA. In 92% of children with GN, the post-vaccination period was uneventful. 8% showed a rise in temperature up to 37.3 Revaccination with DT toxoid in children with GN not only does not cause undesirable changes in the system of immunocompetent cells but also has an immunomodulatory effect, which contributes to the favorable maintenance of the remission period of the disease.

Sections du résumé

Background
Studies aimed at identifying the mechanisms of the immunoregulatory effect of vaccination with diphtheria and tetanus toxoid on the parameters of adaptive immunity in children with kidney pathology are limited. The study aimed to study the effect of revaccination against diphtheria and tetanus on the proliferation and differentiation of immunocompetent cells, the formation of specific antibodies, and the course of the disease in children with glomerulonephritis (GN).
Methods
The study included 45 children with glomerulonephritis (GN) aged 5 to 15 years, in remission from 6 months up to 4 years. Of these, 25 children were revaccinated with DT toxoid (Diphtheria-Tetanus toxoid with reduced antigenic content) and 20 were in the control group (not vaccinated). The frequency of development of local and systemic reactions and the course of GN were assessed. The subpopulation structure of lymphocytes was studied in dynamics after 1-6-12 months by flow cytometry and IgG levels to diphtheria and tetanus were studied by ELISA.
Results
In 92% of children with GN, the post-vaccination period was uneventful. 8% showed a rise in temperature up to 37.3
Conclusion
Revaccination with DT toxoid in children with GN not only does not cause undesirable changes in the system of immunocompetent cells but also has an immunomodulatory effect, which contributes to the favorable maintenance of the remission period of the disease.

Identifiants

pubmed: 34691025
doi: 10.3389/fimmu.2021.715389
pmc: PMC8527030
doi:

Substances chimiques

Antibodies, Bacterial 0
Immunoglobulin G 0
Tetanus Toxoid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

715389

Informations de copyright

Copyright © 2021 Kostinov, Akhmatova, Magarshak, Vlasenko, Polishchuk, Kostinova and Mashilov.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Pediatr Nephrol. 2016 Sep;31(9):1437-48
pubmed: 26450774
Pediatr Nephrol. 2013 Nov;28(11):2125-30
pubmed: 23800800
Front Pharmacol. 2019 Oct 08;10:1192
pubmed: 31649546
J Immunol. 1989 May 1;142(9):3083-90
pubmed: 2785133
Pharmacol Ther. 2010 Oct;128(1):61-81
pubmed: 20600306
Front Pediatr. 2021 Feb 05;8:619548
pubmed: 33634053
J Am Soc Nephrol. 2003 Jul;14(7):1785-93
pubmed: 12819238
Nat Rev Immunol. 2013 Oct;13(10):738-53
pubmed: 24037418
J Biol Chem. 2004 Aug 6;279(32):33071-8
pubmed: 15184382
Kidney Int. 2011 Jan;79(2):189-98
pubmed: 20962742
Indian Pediatr. 2021 Mar 15;58(3):233-236
pubmed: 33713058
Proc Eur Dial Transplant Assoc. 1977;14:209-14
pubmed: 600957
J Am Soc Nephrol. 2004 Jul;15(7):1775-84
pubmed: 15213265
Transplantation. 1997 Jul 27;64(2):237-41
pubmed: 9256180
Int J Mol Sci. 2020 Jun 04;21(11):
pubmed: 32512831
In Vivo. 2017 01-02;31(1):1-22
pubmed: 28064215

Auteurs

Mikhail Petrovich Kostinov (MP)

Department of Allergology, I.I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.
Department of Epidemiology and Modern Vaccination Technologies, Sechenov First Moscow State Medical University, Moscow, Russia.

Nelli Kimovna Akhmatova (NK)

Department of Immunology, I.I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.

Olga Olegovna Magarshak (OO)

Department of Immunology, I.I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.

Anna Egorovna Vlasenko (AE)

Department of Medical Cybernetics and Computer Science Novokuznetsk State Institute for Advanced Training of Physicians, Branch Campus of the Russian Medical Academy of Continuous Professional Education, Novokuznetsk, Russia.

Valentina Borisovna Polishchuk (VB)

Department of Allergology, I.I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.

Aristitsa Mikhailovna Kostinova (AM)

Department of Immunology, NRC Institute of Immunology FMBA of Russia, Moscow, Russia.

Kirill Vadimovich Mashilov (KV)

Department of Allergology, I.I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH